Novavax (NVAX) stock forecast for 2024. Forecast tables and graphs.

Novavax (NVAX) stock forecast for 2024

The forecast has been updated: June 10, 2021 12:20


Novavax stock price online today

Analyst Target Price

258

Dividend Date

10.05.2019

Ex Dividend Date

-

Last Split Factor

1:20

Last Split Date

10.05.2019

Should you buy or sell Novavax stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $258 target price for Novavax stock stock.

Today 200 Day Moving Average is the resistance level (176.5962 $).

50 Day Moving Average is the resistance level (175.2946 $).




NVAX Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 123.04 111.60 140.39 20.51 %
Feb 137.80 104.73 150.62 30.47 %
Mar 159.30 145.92 189.41 22.96 %
Apr 137.80 109.69 166.73 34.22 %
May 168.39 130.50 201.73 35.31 %
Jun 196.68 159.50 226.18 29.48 %
Jul 213.79 197.11 249.06 20.86 %
Aug 253.55 203.35 300.71 32.38 %
Sep 267.24 242.39 306.53 20.92 %
Oct 195.09 177.53 221.42 19.82 %
Nov 213.82 175.33 230.49 23.93 %
Dec 208.68 162.98 256.26 36.40 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.


Novavax overview

Novavax Address

21 Firstfield Road, Gaithersburg, MD, United States, 20878

Market Capitalization

15 705 790 464 $

EBITDA

-157 414 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-8.597

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

131.434

Trailing PE

0

Forward PE

28.4091

EV To Revenue

13.0758

EV To EBITDA

0

52 Week High

331.68

52 Week Low

43.11

50 Day Moving Average

175.2946

200 Day Moving Average

176.5962

Shares Outstanding

74094400

Shares Float

73339861

Shares Short Prior Month

4451342

Short Ratio

1.18

Percent Insiders

0.553

Percent Institutions

58.197

Novavax stock forecast for this year


Novavax stock forecast for Jan 2024.
Estimated Average Forecasted Novavax Price: 123.04. Negative monthly dynamics of the instrument is expected with 20.508% volatility is expected.

Pessimistic forecast: 111.60

Optimistic: 140.39


Novavax stock forecast for Feb 2024.
Estimated Average Forecasted Novavax Price: 137.80. Positive monthly dynamics of the instrument is expected with 30.467% volatility is expected.

Pessimistic forecast: 104.73

Optimistic: 150.62


Novavax stock forecast for Mar 2024.
Estimated Average Forecasted Novavax Price: 159.30. Positive monthly dynamics of the instrument is expected with 22.960% volatility is expected.

Pessimistic forecast: 145.92

Optimistic: 189.41


Novavax stock forecast for Apr 2024.
Estimated Average Forecasted Novavax Price: 137.80. Negative monthly dynamics of the instrument is expected with 34.215% volatility is expected.

Pessimistic forecast: 109.69

Optimistic: 166.73


Novavax stock forecast for May 2024.
Estimated Average Forecasted Novavax Price: 168.39. Positive monthly dynamics of the instrument is expected with 35.309% volatility is expected.

Pessimistic forecast: 130.50

Optimistic: 201.73


Novavax stock forecast for Jun 2024.
Estimated Average Forecasted Novavax Price: 196.68. Positive monthly dynamics of the instrument is expected with 29.478% volatility is expected.

Pessimistic forecast: 159.50

Optimistic: 226.18


Novavax stock forecast for Jul 2024.
Estimated Average Forecasted Novavax Price: 213.79. Positive monthly dynamics of the instrument is expected with 20.858% volatility is expected.

Pessimistic forecast: 197.11

Optimistic: 249.06


Novavax stock forecast for Aug 2024.
Estimated Average Forecasted Novavax Price: 253.55. Positive monthly dynamics of the instrument is expected with 32.378% volatility is expected.

Pessimistic forecast: 203.35

Optimistic: 300.71


Novavax stock forecast for Sep 2024.
Estimated Average Forecasted Novavax Price: 267.24. Positive monthly dynamics of the instrument is expected with 20.924% volatility is expected.

Pessimistic forecast: 242.39

Optimistic: 306.53


Novavax stock forecast for Oct 2024.
Estimated Average Forecasted Novavax Price: 195.09. Negative monthly dynamics of the instrument is expected with 19.824% volatility is expected.

Pessimistic forecast: 177.53

Optimistic: 221.42


Novavax stock forecast for Nov 2024.
Estimated Average Forecasted Novavax Price: 213.82. Positive monthly dynamics of the instrument is expected with 23.933% volatility is expected.

Pessimistic forecast: 175.33

Optimistic: 230.49


Novavax stock forecast for Dec 2024.
Estimated Average Forecasted Novavax Price: 208.68. Negative monthly dynamics of the instrument is expected with 36.400% volatility is expected.

Pessimistic forecast: 162.98

Optimistic: 256.26



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.91 (14.06.2021) -2.09 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.14 (14.06.2021) -1.26 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.